TAMPA, Fla., Sept. 20, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets:RXPC), one of the nation's leading sources of low-cost prescription medications, today announces that in an effort to increase its sales and marketing initiatives it has retained the services of William A. Folino. RX Processing will benefit from Mr. Folino's twenty-four years of experience with major industry leaders including 13 years at SmithKline Beecham/Quest Diagnostics, and Roche Bio-Medical/Lab Corp of America. He is a proven sales leader in the clinical pathology laboratory service industry and possesses clinical and business development expertise.
Mr. Folino joins Rx Processing as the Director of Marketing and Sales. His focus will be on developing a strategic marketing and sales approach to target large market growth areas including; assisted living facilities, managed care insurance groups, and large employee unions. According to Mr. Folino, "I look forward to growing RXPC to be the premiere low-cost provide of prescription drugs. I am joining a strong corporation to target large networks and groups that can benefit by offering their members the lowest cost medicines available worldwide. We are one of the first corporations of this kind and I look forward to the challenge that lies ahead."
"We believe William has the ability and experience to bring Rx Processing into large previously untapped markets," said Peter Fiorillo, President of Rx Processing. "William is aware of what many other top industry executives have been hiding, that the drug industry has made up the story that the practice of re-importing drugs from Canada presents a safety issue for Americans. This was further acknowledged recently by a top industry executive, Peter Rost, vice president of marketing for Pfizer, who according to the Washington Post, stated that 'the real concern about safety is about people who do not take drugs because they cannot afford it. The safety issue is a made-up story.' RX Corporation pledges to adhere to the highest safety standards while continuing to improve the lives of ordinary Americans by delivering safe and affordable medications."
About Rx Processing Corporation
RX Corporation (RXPC) is a market leader in providing prescription drugs to US Citizens, corporations, unions, and prescription benefit plans through licensed pharmacies in the United States and Canada. The Company works with licensed pharmacies and provides access to over 1500 approved name brand and generic medications ready for distribution in the US market. Utilizing Rx Processing, U.S. citizens can save 25%-84% on their daily prescriptions. These reduced cost medications are available at the Company's affiliate retail storefronts and information about the company can be found at www.rxprocessingcorp.com.
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.